Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling

Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival

(2020) Antonio Giovanni Solimando et al.   BLOOD

An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates

(2020) Jermaine Goveia et al.   CANCER CELL

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

(2020) John D. Martin et al.   Nature Reviews Clinical Oncology

Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma

(2020) Arghya Ray et al.   ONCOGENE

Immune system and bone microenvironment: rationale for targeted cancer therapies

(2020) Gnoni Antonio et al.   Oncotarget

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma

(2020) Giuseppe Di Lernia et al.   Journal of Clinical Medicine

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro

(2020) Markus Krebs et al.   Journal of Clinical Medicine

HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma

(2020) Luigia Rao et al.   Cancers

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma

(2020) Ilaria Saltarella et al.   Cells

Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression.

(2020) Antonio G. Solimando et al.   HAEMATOLOGICA

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside

(2020) Antonio G. Solimando et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance

(2020) Vanessa Desantis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Spatial heterogeneity of oxygenation and haemodynamics in breast cancer resolved in vivo by conical multispectral optoacoustic mesoscopy

(2020) Jiao Li et al.   Light-Science & Applications

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors

(2020) Lara Gibellini et al.   Frontiers in Immunology

Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma

(2020) Antonella Argentiero et al.   Journal of Clinical Medicine

A Comprehensive Biological and Clinical Perspective Can Drive a Patient-Tailored Approach to Multiple Myeloma: Bridging the Gaps between the Plasma Cell and the Neoplastic Niche

(2020) Antonio Giovanni Solimando et al.   Journal of Oncology

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

(2020) Yuanyuan Zhang et al.   Cellular & Molecular Immunology

Targeting immune checkpoints in hematological malignancies

(2020) Basit Salik et al.   Journal of Hematology & Oncology

A decade of immune-checkpoint inhibitors in cancer therapy

(2020) Caroline Robert   Nature Communications

Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell–Cell Interactions in Tumor Progression

(2020) Adam Lauko et al.   CANCER RESEARCH

Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

(2020) Won Suk Lee et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study

(2020) Sebastiano Cicco et al.   Life-Basel

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

(2019) Jérôme Galon et al.   NATURE REVIEWS DRUG DISCOVERY

Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors

(2019) Maria M. Steele et al.   Jove-Journal of Visualized Experiments

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer

(2019) Letizia Porcelli et al.   Cancers

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

(2019) Vicky Makker et al.   LANCET ONCOLOGY

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

(2019) Filipe Martins et al.   Nature Reviews Clinical Oncology

Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues

(2019) Filipa Gil Marques et al.   RADIOTHERAPY AND ONCOLOGY

Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment

(2019) Heidi Harjunpää et al.   Frontiers in Immunology

Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages

(2019) Marco Orecchioni et al.   Frontiers in Immunology

High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment

(2019) Antonio Giovanni Solimando et al.   Journal of Clinical Medicine

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study

(2019) Antonella Argentiero et al.   Cancers

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

(2019) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor angiogenesis: causes, consequences, challenges and opportunities

(2019) Roberta Lugano et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS

(2019) Marcel Seibold et al.   HAEMATOLOGICA

Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

(2019) Longo et al.   Medicina-Lithuania

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib

(2019) Oronzo Brunetti et al.   Medicina-Lithuania

Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies

(2019) Antonio Gnoni et al.   Medicina-Lithuania

CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement

(2019) Matteo Claudio Da Vià et al.   ONCOLOGIST

Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs

(2019) Patrizia Leone et al.   Journal of Clinical Medicine

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

(2019) Joseph A. Flores-Toro et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development

(2019) Jie Feng et al.   Cancers

Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma

(2018) Vanessa Desantis et al.   ANNALS OF HEMATOLOGY

Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial

(2018) Angelo Vacca et al.   CLINICAL IMMUNOLOGY

Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer

(2018) et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Increased vessel perfusion predicts the efficacy of immune checkpoint blockade

(2018) Xichen Zheng et al.   JOURNAL OF CLINICAL INVESTIGATION

Phenotype molding of stromal cells in the lung tumor microenvironment

(2018) Diether Lambrechts et al.   NATURE MEDICINE

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

(2018) Dai Fukumura et al.   Nature Reviews Clinical Oncology

Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa

(2018) Kabir A. Khan et al.   Nature Reviews Clinical Oncology

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

(2018) Robert J. Motzer et al.   NEW ENGLAND JOURNAL OF MEDICINE

The dark side of tumor-associated endothelial cells

(2018) Francesco De Sanctis et al.   SEMINARS IN IMMUNOLOGY

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy

(2018) Marco B. Schaaf et al.   Cell Death & Disease

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

(2018) Thomas Duhen et al.   Nature Communications

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma

(2018) Aurelia Lamanuzzi et al.   Oncotarget

Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study

(2018) Luigia Rao et al.   Oncotarget

Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer

(2018) Young Kwang Chae et al.   Scientific Reports

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics

(2018) Ahmed M.E. Abdalla et al.   Theranostics

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy

(2018) Adriana Albini et al.   Frontiers in Immunology

Unraveling the Role of Angiogenesis in Cancer Ecosystems

(2018) Iratxe Zuazo-Gaztelu et al.   Frontiers in Oncology

Unleashing endogenous TNF-alpha as a cancer immunotherapeutic

(2018) Steven F. Josephs et al.   Journal of Translational Medicine

A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis

(2018) Antonio G. Solimando et al.   MEDICINE

Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment

(2018) Kaitlin Graham et al.   International Journal of Nanomedicine

Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes

(2018) Maria Antonia Frassanito et al.   JOURNAL OF PATHOLOGY

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer

(2018) Maria Georganaki et al.   Frontiers in Immunology

Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients

(2018) Patrizia Leone et al.   OncoImmunology

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment

(2017) Martina Rudelius et al.   HAEMATOLOGICA

Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy

(2017) Keehoon Jung et al.   JOURNAL OF CLINICAL INVESTIGATION

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma

(2017) A G Solimando et al.   LEUKEMIA

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

(2017) Lin Tian et al.   NATURE

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

(2017) Mizuki Nishino et al.   Nature Reviews Clinical Oncology

In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors

(2017) Tommaso Torcellan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein

(2017) Imen Jridi et al.   TOXICON

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche

(2017) Michael P. Plebanek et al.   Nature Communications

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment

(2017) Martina Rudelius et al.   HAEMATOLOGICA

Ral signaling pathway in health and cancer

(2017) Adel Rezaei Moghadam et al.   Cancer Medicine

Next-generation in vivo optical imaging with short-wave infrared quantum dots

(2017) Oliver T. Bruns et al.   Nature Biomedical Engineering

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

(2016) Alan L. Chang et al.   CANCER RESEARCH

Targeting regulatory T cells in tumors

(2016) Chang Liu et al.   FEBS Journal

Lymphatic vessels regulate immune microenvironments in human and murine melanoma

(2016) Amanda W. Lund et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting vasculogenesis to prevent progression in multiple myeloma

(2016) M Moschetta et al.   LEUKEMIA

Targeting B-cell non Hodgkin lymphoma: New and old tricks

(2016) Antonio Giovanni Solimando et al.   LEUKEMIA RESEARCH

Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors

(2016) J Stalin et al.   ONCOGENE

Tumor cell vascular mimicry: Novel targeting opportunity in melanoma

(2016) Mary J.C. Hendrix et al.   PHARMACOLOGY & THERAPEUTICS

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages

(2016) Teresa E. Peterson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer

(2016) Diane Pannier et al.   Oncology Letters

Intraoperative intravital microscopy permits the study of human tumour vessels

(2016) Daniel T. Fisher et al.   Nature Communications

Microenvironment drug resistance in multiple myeloma: emerging new players

(2016) Lucia Di Marzo et al.   Oncotarget

Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity

(2016) John D. Martin et al.   Cold Spring Harbor Perspectives in Medicine

Hypoxia and metabolic adaptation of cancer cells

(2016) K L Eales et al.   Oncogenesis

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment

(2016) Shona A. Hendry et al.   Frontiers in Immunology

T Cell Trafficking through Lymphatic Vessels

(2016) Morgan C. Hunter et al.   Frontiers in Immunology

Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan

(2016) Nako Maishi et al.   Scientific Reports

dendextend: an R package for visualizing, adjusting and comparing trees of hierarchical clustering

(2015) Tal Galili   BIOINFORMATICS

Targeting the tumor vasculature to enhance T cell activity

(2015) Evripidis Lanitis et al.   CURRENT OPINION IN IMMUNOLOGY

VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation

(2015) Hua Huang et al.   FASEB JOURNAL

HIF-1 at the crossroads of hypoxia, inflammation, and cancer

(2015) Kuppusamy Balamurugan   INTERNATIONAL JOURNAL OF CANCER

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients

(2015) Sara M. Tolaney et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

T cell exclusion, immune privilege, and the tumor microenvironment

(2015) J. A. Joyce et al.   SCIENCE

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus

(2015) Kevin R. Kelly et al.   Oncotarget

Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3

(2014) Meghan B. Azad et al.   Autophagy

Role of endothelial progenitor cells in cancer progression

(2014) Michele Moschetta et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia

(2014) Rakesh K. Jain   CANCER CELL

Cell adhesion molecules and their relation to (cancer) cell stemness

(2014) Ensieh Farahani et al.   CARCINOGENESIS

A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target

(2014) A. Ferrucci et al.   CLINICAL CANCER RESEARCH

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Functional polarization of tumour-associated macrophages by tumour-derived lactic acid

(2014) Oscar R. Colegio et al.   NATURE

Integrin  9 on lymphatic endothelial cells regulates lymphocyte egress

(2014) K. Ito et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells

(2014) Sarah K Maenhout et al.   OncoImmunology

Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma

(2013) Lin Zhang et al.   BMC CANCER

Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy

(2013) Y. Huang et al.   CANCER RESEARCH

Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy

(2013) D. Gerald et al.   CANCER RESEARCH

Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma

(2013) M. Moschetta et al.   CLINICAL CANCER RESEARCH

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

(2013) Rakesh K. Jain   JOURNAL OF CLINICAL ONCOLOGY

Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor–specific angiogenic signaling

(2013) Swetha S. D. Peddibhotla et al.   MOLECULAR BIOLOGY OF THE CELL

Mouse models for studying angiogenesis and lymphangiogenesis in cancer

(2013) Lauri Eklund et al.   Molecular Oncology

Influence of tumour micro-environment heterogeneity on therapeutic response

(2013) Melissa R. Junttila et al.   NATURE

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

Cancer Immunotherapy

(2013) J. Couzin-Frankel   SCIENCE

Targeting Angiogenesis and the Tumor Microenvironment

(2013) Jennifer Samples et al.   Surgical Oncology Clinics of North America

Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules

(2013) E Leich et al.   Blood Cancer Journal

Antiangiogenic Therapies: Going beyond Their Limits

(2013) L. Moserle et al.   Cancer Discovery

From seeing to believing: labelling strategies for in vivo cell-tracking experiments

(2013) F. Progatzky et al.   Interface Focus

Role of non-classical MHC class I molecules in cancer immunosuppression

(2013) Grazyna Kochan et al.   OncoImmunology

Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration

(2012) E. Rossi et al.   BLOOD

Expression of cell adhesion molecules and prognosis in breast cancer

(2012) S. Saadatmand et al.   BRITISH JOURNAL OF SURGERY

T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis

(2012) A. Facciabene et al.   CANCER RESEARCH

Bone Marrow Microenvironment in Multiple Myeloma Progression

(2012) S. Manier et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors

(2012) Alicia S Chung et al.   JOURNAL OF PATHOLOGY

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

(2012) Y. Huang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

(2012) S. J. Conley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma

(2012) Roberto Ria et al.   Stem Cells International

Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape

(2012) Salem Chouaib et al.   Frontiers in Immunology

HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF

(2011) Charlotte Rolny et al.   CANCER CELL

Egfl7 Promotes Tumor Escape from Immunity by Repressing Endothelial Cell Activation

(2011) S. Delfortrie et al.   CANCER RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma

(2011) Masahiro Abe   INTERNATIONAL JOURNAL OF HEMATOLOGY

Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts

(2011) Veronique Lorgis et al.   JOURNAL OF NEURO-ONCOLOGY

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

(2011) Shom Goel et al.   PHYSIOLOGICAL REVIEWS

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

(2011) M. Gooden et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Extracellular Matrix Degradation and Remodeling in Development and Disease

(2011) P. Lu et al.   Cold Spring Harbor Perspectives in Biology

Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability

(2010) I. M. Pires et al.   CANCER RESEARCH

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

(2010) John M. Heddleston et al.   CELL CYCLE

Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas

(2010) S.-S. Chae et al.   CLINICAL CANCER RESEARCH

Chemokines and chemokine receptors: new insights into cancer-related inflammation

(2010) Gwendal Lazennec et al.   TRENDS IN MOLECULAR MEDICINE

In Vivo Imaging in Cancer

(2010) J. Condeelis et al.   Cold Spring Harbor Perspectives in Biology

The roles of cell adhesion molecules in tumor suppression and cell migration

(2010) Mei Chung Moh et al.   Cell Adhesion & Migration

Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents

(2009) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise

(2009) Sara Rockwell et al.   CURRENT MOLECULAR MEDICINE

Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging

(2009) Benjamin J Vakoc et al.   NATURE MEDICINE

The angiogenic switch in carcinogenesis

(2009) Vanessa Baeriswyl et al.   SEMINARS IN CANCER BIOLOGY

Antiangiogenesis in haematological malignancies

(2008) William W. Li et al.   BRITISH JOURNAL OF HAEMATOLOGY

IFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers

(2008) Bin Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

(2008) Juliana Hamzah et al.   NATURE

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE

Monitoring cellular movement in vivo with photoconvertible fluorescence protein "Kaede" transgenic mice

(2008) M. Tomura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis

(2008) D. Gao et al.   SCIENCE